A Randomised Trial of Subcutaneous Intermittent Interleukin-2 without Antiretroviral Therapy in HIV-Infected Patients: The UK-Vanguard Study
2007
A Trial of Interleukin-2 in HIV Patients
publication
Author Information
Author(s): Sean Emery
Takeaway
This study looked at a treatment for HIV patients using a substance called interleukin-2 without standard HIV medications.
Potential Biases
The author has received research support from several pharmaceutical companies.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website